Pilot and Feasibility Program

试点和可行性计划

• 批准号: 10394908
• 负责人: Randall Lee Mynatt
• 金额: $ 16.79万
• 依托单位: LSU PENNINGTON BIOMEDICAL RESEARCH CTR
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-07-01 至 2026-04-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10394908
• 关键词: Application procedure; Applications Grants; Award; Biomedical Research; Botanicals; Centers of Research Excellence; Collaborations; Communication; Direct Costs; Discipline; Eligibility Determination; Evaluation; Feedback; Felis catus; Fostering; Foundations; Funding; Goals; Grant; Health; Health Sciences; Individual; Infrastructure; Institution; Leadership; Letters; Longevity; Louisiana; Mentors; Metabolic; Methods; Monitor; Obesity; Philanthropic Fund; Positioning Attribute; Postdoctoral Fellow; Privatization; Process; Productivity; Research; Research Personnel; Research Proposals; Resources; Running; Scientist; Secure; Senior Scientist; Sister; Translational Research; United States National Institutes of Health; Work; base; career; cost; innovation; medical schools; member; multidisciplinary; nutrition; programs; research and development; synergism; tool; translational study

PROJECT SUMMARY / ABSTRACT (PILOT AND FEASIBILITY PROGRAM) The Pilot and Feasibility (P&F) Program is a critical and integral component of the Pennington/Louisiana NORC. The purpose is to stimulate outstanding research in nutrition and obesity which is aligned with our NORC programmatic theme “Nutrition, Obesity and Metabolic Health through the Lifespan.” The NORC gives highest priority to translational research related to NORC theme(s). Awards are primarily to young promising investigators to help establish their research careers. The selected research proposals receive funds to support costs of the project plus use of the NORC Scientific Cores. Although the level of support from this program for each individual project is relatively modest, this type of start-up funding is frequently the most difficult to identify in the research setting. Institutional commitment of funds to the NORC P&F Program has been strong and consistent with Pennington Biomedical contributing approximately 50% of the total money put into the NORC P&F program. We expect to at least keep the current level of institutional support and even aim to increase it in the next funding cycle (from sister Louisiana academic institutions and philanthropy). With these institutional funds, the P&F Program has been innovative and supported new initiatives such as multi- disciplinary and multi-institutional proposal solicitations to stimulate collaboration and has worked collaboratively with other centers to leverage resources. The P&F Program has operated efficiently and has yielded outstanding productivity. Overall, from 2004 to November 2020, 58% of all P&F award recipients have received additional investigator-initiated funding. The P&F grant program is a vibrant part of the NORC, enabling exciting new lines of research that have resulted in successful new K and R proposals and awards. According to members’ feedback, the P&F Program is running smoothly and achieving its purpose of stimulating research. Based on the existing infrastructure, we will now expand the Program to increase the integration of Louisiana NORC institutions, using committed institutional funds and potentially more philanthropic funding from our Pennington Biomedical Research Foundation.

项目摘要 /摘要（飞行员和可行性计划） 飞行员和可行性（P＆F）计划是Pennington/Louisiana Norc的关键和组成部分。 目的是刺激与我们的NORC保持一致的营养和肥胖方面的杰出研究 程序化主题“通过生命周期中的营养，肥胖和代谢健康。” NORC给出了最高的 优先于与NORC主题有关的翻译研究。奖项是年轻承诺的主要奖项 调查人员帮助建立他们的研究事业。选定的研究提案获得资金 支持项目的成本以及NORC科学核心的使用。虽然从中获得的支持水平 每个项目的程序都是相对谦虚的，这种类型的启动资金通常是最大的 在研究环境中很难识别。资金对NORC P＆F计划的机构承诺已有 我们坚强并且与彭宁顿生物医学一致，约占总资金的50％ 进入NORC P＆F计划。我们希望至少保持当前的机构支持水平，甚至瞄准 在下一个资金周期（来自路易斯安那州姐妹学术机构和慈善事业）中增加了它。和 这些机构资金，p＆f计划具有创新性，并支持了新计划，例如 纪律和多机构的提案征集以刺激协作，并有效 与其他中心合作以利用资源。 P＆F计划已经有效地运营了 产生了出色的生产力。总体而言，从2004年到2020年11月，所有P＆F奖励者中有58％有 收到了额外的调查员发起的资金。 P＆F赠款计划是NORC的充满活力的部分，使 令人兴奋的新研究线已成功获得了新的K和R建议和奖项。根据 成员的反馈，P＆F计划正在顺利进行，并实现了刺激研究的目的。 根据现有的基础架构，我们现在将扩展该计划以增加路易斯安那州的集成 NORC机构，使用承诺的机构资金，并可能从我们的 彭宁顿生物医学研究基金会。